Clinical Trial Update: Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial update on PACK-CXL for infectious keratitis concluded.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infectious Disease
• Keratitis

Drugs mentioned

• PACK-CXL (photoactivated collagen cross-linking)

Snippet

Sponsor: University Hospital, Geneva | Conditions: Keratitis; Infectious Disease (Manifestation) | Phase 3 | Status: COMPLETED